Application of human Nectin-2 protein

Active Publication Date: 2015-03-18
BEIJING VDJBIO
View PDF2 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

In previous reports, there are many studies on the genes related to hyperlipidemia, such as ApoE, ApoC1 and Tomm40, and these genes are located on the same chromosome, and

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Application of human Nectin-2 protein
  • Application of human Nectin-2 protein
  • Application of human Nectin-2 protein

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0033]Example 1 Obtaining of human Nectin-2 protein

[0034] According to the human Nectin-2 mRNA sequence published in GenBank (Accession No.: CR456818.1), the 1-1035th nucleotide sequence was spliced ​​with the gene sequence of the immunoglobulin Fc fragment. The spliced ​​gene sequence is shown in SEQ ID No.5 is shown.

[0035] After the above sequence was artificially synthesized, it was cloned into the mammalian expression vector pcDNA3.1, and the constructed expression vector was transiently transferred into HEK293 cells to realize the expression of the fusion protein and purify the target protein. The results of SDS-PAGE gel electrophoresis after protein purification are as follows: figure 2 shown.

[0036] The specific process of cell transfection, cell culture and protein purification is as follows: First, HEK293 cells were cultured in suspension in 293FreeStyle medium (GIBCO) in 5% CO 2 Cultivate under conditions, the speed of the carbon dioxide shaker (INFORS) i...

Embodiment 2

[0037] Example 2 Application of Human Nectin-2 Protein in Suppressing Obesity

[0038] In order to verify the anti-obesity effect of the Nectin-2 protein prepared in Example 1, the following high-fat diet-induced obesity mouse model was constructed in this example:

[0039] 6-week-old C57BL / 6J male mice were fed with 60Kcal% high-fat diet (Research diet, D12451), and body weight was recorded every week. After 8 weeks of induction and waiting for their obesity, the high-fat diet-induced obesity group was randomly divided into a control group (IgG, 10) and an experimental group (Nectin-2, 10); then the experimental group was treated with Nectin-2 (Example 1) treated with subcutaneous injection at a dose of 5 mg / kg body weight / week; and the control group was treated with the same dose of IgG (immunoglobulin Fc as the control protein), administered by subcutaneous injection, administered weekly 2 weeks before the administration, the average daily food intake of the animals in eac...

Embodiment 3

[0041] Example 3 Application of Human Nectin-2 Protein in Lowering Fasting Blood Glucose

[0042] Existing research results have shown that obesity is often accompanied by severe insulin resistance. In the present embodiment, the following experiments were further carried out on the mice administered in the 9th week in Example 2:

[0043] After 9 weeks of administration in Example 2, the mice were fasted overnight to measure the fasting blood glucose level.

[0044] The result is as Figure 4 As shown, the fasting blood glucose (5.84mmol) of the control group (IgG) induced by high-fat diet was significantly higher than that of the experimental group treated with Nectin-2 (5.2mmol, p<0.05).

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

Provided are uses of human Nectin-2 protein. Nectin-2 protein, derived protein thereof or modified protein thereof can effectively inhibit obesity and diabetes, and are also used to treat obesity-related diseases including hypertension, and hyperlipemia, etc. The Nectin-2 protein not only reduces blood glucose, but also improves the body glucose metabolism, and enhances sensitivity to tissue insulin by improving energy metabolism of the body, and improves adaptability to cold stimulation by activating fatty acid metabolism of the body.

Description

technical field [0001] The invention relates to the field of biomedicine, in particular to the application of human Nectin-2 protein. Background technique [0002] The occurrence of obesity is the result of the body's energy metabolism disorder, that is, when the body's energy intake exceeds energy consumption, the remaining energy is almost completely converted into fat and stored in the white fat of the whole body. Obesity is not only an independent disease, but also a predisposing factor for type Ⅱ diabetes, cardiovascular disease, hypertension, stroke and various cancers. Obesity is showing an explosive trend worldwide. At present, there are more than 270 million overweight people in my country, and more than 96 million obese people. Obesity induces many diseases including: type Ⅱ diabetes, non-alcoholic fatty liver, gallstones, cardiovascular disease and Alzheimer's disease, and some are even the main predisposing factors of cancer. Obesity refers to a certain degree ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
IPC IPC(8): C07K16/46C12N15/13C12N1/19C12N1/15C12N1/21C12N5/10A61K39/395A61P3/04A61P3/10A61P43/00
CPCC12N5/10C07K2319/30C07K14/705A61K38/00A61P3/04A61P3/10A61P43/00C07K14/70503
Inventor 李自强
Owner BEIJING VDJBIO
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap